Senate Clears Hamburg for FDA | GenomeWeb

NEW YORK (GenomeWeb News) – The US Senate yesterday confirmed Margaret Hamburg, a biothreat expert with experience running a large organization in New York, and with studying pathogens at the National Institutes of Health, to take over as commissioner at the Food and Drug Administration.

Department of Health and Human Services Director Kathleen Sebelius in a statement called Hamburg "an inspiring public health leader with broad experience in infectious disease, bioterrorism, and health policy. "Her expertise and judgment will serve FDA well," Sebelius said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.